Abdominal Functional Electrical Stimulation to improve bowel and bladder function in Multiple Sclerosis

Not Applicable

Completed

• Conditions: Multiple Sclerosis; Functional Constipation; Bladder incontinence; Neurological - Multiple sclerosis; Renal and Urogenital - Other renal and urogenital disorders; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12618000464268
• Lead Sponsor: euroscience Research Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-03-29
• Study Completion: 2019-04-19
• Last Update Posted: 15 July 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 23

Inclusion Criteria

Adults with diagnosed MS and an Expanded Disability Status Scale score of 3 to 8, who are able to eat and drink normally, fulfil the Rome III criteria for functional constipation, and constipated for at least three months.

Exclusion Criteria

Current urinary tract infection, pregnancy, history of irritable bowel syndrome, organic bowel obstruction or other bowel disease, physical obstacles that prevent Abdominal FES (e.g. abdominal trauma, pacemaker), no response to Abdominal FES (e.g. lower motor neuron impairment), taking medication designed to alter bowel or bladder function.

Study & Design

• Study Type: Interventional
• Study Design: Not specified